Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,585.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 2,715.00
  • 52 Week Low: 1,548.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 26,135
  • Market Cap: £1,720.00m
  • RiskGrade: 128
  • Beta: 1.17

Latest ShareCast News

Berenberg starts Genus at 'buy', cites protein demand and China opportunity

By Iain Gilbert

Date: Wednesday 26 Nov 2025

(Sharecast News) - Analysts at Berenberg initiated coverage on genetics firm Genus with a 'buy' rating and a 3,050p target price on Wednesday, stating the "long-term underlying dynamics" of the business "look attractive".

Genus Regulatory News

Director/PDMR Shareholding 27-Nov-2025 07:00 RNS
Results of AGM 19-Nov-2025 12:12 RNS
Non-Executive Director Appointments 19-Nov-2025 07:00 RNS
AGM Trading Update 19-Nov-2025 07:00 RNS
Total Voting Rights 03-Nov-2025 10:56 RNS

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,585.00p
Change Today -10.00p
% Change -0.39 %
52 Week High 2,715.00
52 Week Low 1,548.00
Volume 26,135
Shares Issued 66.54m
Market Cap £1,720.00m
Beta 1.17
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 15-Jan-2026

Time Volume / Share Price
14:59 24 @ 2,585.00p
14:59 70 @ 2,585.00p
14:58 32 @ 2,585.00p
14:57 33 @ 2,585.00p
14:55 32 @ 2,585.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page